<DOC>
	<DOCNO>NCT01823887</DOCNO>
	<brief_summary>The ANTHEM-HF Study design demonstrate safety efficacy vagus nerve stimulation ( VNS ) Cyberonics VNS Therapy System treatment subject symptomatic heart failure .</brief_summary>
	<brief_title>Autonomic Neural Regulation Therapy Enhance Myocardial Function Heart Failure ( ANTHEM-HF ) Study</brief_title>
	<detailed_description>Heart failure patient enrol randomized cervical VNS implantation either leave side right side . After 2-week post-implantation recovery period 10-week stimulation titration period , continuous periodic stimulation perform 6 month , data collection 3 month 6 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients symptomatic heart failure , New York Heart Association ( NYHA ) class II/III reduce EF dilate heart</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Vagus Nerve</keyword>
	<keyword>VNS</keyword>
</DOC>